[go: up one dir, main page]

DE60133734D1 - Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen - Google Patents

Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Info

Publication number
DE60133734D1
DE60133734D1 DE60133734T DE60133734T DE60133734D1 DE 60133734 D1 DE60133734 D1 DE 60133734D1 DE 60133734 T DE60133734 T DE 60133734T DE 60133734 T DE60133734 T DE 60133734T DE 60133734 D1 DE60133734 D1 DE 60133734D1
Authority
DE
Germany
Prior art keywords
bordetella
pertactin
pertussis
repeated regions
parapertussis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133734T
Other languages
English (en)
Other versions
DE60133734T2 (de
Inventor
Nicole Guiso-Maclouf
Caroline Boursaux-Eude
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of DE60133734D1 publication Critical patent/DE60133734D1/de
Publication of DE60133734T2 publication Critical patent/DE60133734T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60133734T 2000-05-25 2001-05-23 Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen Expired - Lifetime DE60133734T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20696900P 2000-05-25 2000-05-25
US206969P 2000-05-25
PCT/EP2001/006457 WO2001090143A2 (en) 2000-05-25 2001-05-23 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions

Publications (2)

Publication Number Publication Date
DE60133734D1 true DE60133734D1 (de) 2008-06-05
DE60133734T2 DE60133734T2 (de) 2009-05-14

Family

ID=22768696

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133734T Expired - Lifetime DE60133734T2 (de) 2000-05-25 2001-05-23 Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Country Status (11)

Country Link
US (3) US7070779B2 (de)
EP (1) EP1284993B1 (de)
JP (1) JP2003533990A (de)
AT (1) ATE393166T1 (de)
AU (1) AU2001267527A1 (de)
CY (1) CY1110430T1 (de)
DE (1) DE60133734T2 (de)
DK (1) DK1284993T3 (de)
ES (1) ES2303833T3 (de)
PT (1) PT1284993E (de)
WO (1) WO2001090143A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) * 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
DE60133734T2 (de) 2000-05-25 2009-05-14 Institut Pasteur Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
JP5398527B2 (ja) 2007-05-28 2014-01-29 北里第一三共ワクチン株式会社 パラ百日咳菌全菌体ワクチン組成物
CU23679A1 (es) * 2007-10-30 2011-07-11 Ct Ingenieria Genetica Biotech Variantes de pertactinas para uso vacunal
EP2430040A1 (de) * 2009-05-11 2012-03-21 Novartis AG Antigenaufreinigungs­verfahren für pertactinantigen
US8261986B2 (en) * 2009-10-21 2012-09-11 Kevin Kwong-Tai Chung System and method for decoding an optically readable markable sheet and markable sheet therefor
BR112013019850B1 (pt) * 2011-02-04 2023-02-28 Zoetis Services Llc Composições de vacina e seu uso no tratamento ou prevenção de doenças respiratórias infecciosas caninas
WO2012104821A1 (en) * 2011-02-04 2012-08-09 Pfizer Inc. Immunogenic bordetella bronchiseptica compositions
CN109879942A (zh) * 2019-03-01 2019-06-14 浙江省农业科学院 一种兔波氏杆菌外膜蛋白及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9007416D0 (en) * 1990-04-02 1990-05-30 Wellcome Found Expression of heterologous protein in yeast
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
FR2728170A1 (fr) * 1994-12-15 1996-06-21 Pasteur Institut Vaccin de type acellulaire anti-bordetella
DE60133734T2 (de) 2000-05-25 2009-05-14 Institut Pasteur Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen

Also Published As

Publication number Publication date
WO2001090143A2 (en) 2001-11-29
US7070779B2 (en) 2006-07-04
JP2003533990A (ja) 2003-11-18
ES2303833T3 (es) 2008-09-01
DE60133734T2 (de) 2009-05-14
EP1284993B1 (de) 2008-04-23
US20030180307A1 (en) 2003-09-25
PT1284993E (pt) 2008-06-11
AU2001267527A1 (en) 2001-12-03
WO2001090143A3 (en) 2002-09-26
ATE393166T1 (de) 2008-05-15
DK1284993T3 (da) 2008-07-28
CY1110430T1 (el) 2012-05-23
US20060008474A1 (en) 2006-01-12
EP1284993A2 (de) 2003-02-26
US7314910B2 (en) 2008-01-01
US6964767B2 (en) 2005-11-15
US20040166116A9 (en) 2004-08-26
US20020192237A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
EA200300348A1 (ru) Спирогетероциклические нитрилы, пригодные для применения в качестве обратимо действующих ингибиторов цистеиновых протеаз
DK1660528T3 (da) Mutein af tåre-lipocalin
SE0001899D0 (sv) New compounds
ATE128974T1 (de) Neue kondensierte heterocyclische verbindungen und ihre verwendung für heilmittel.
DK0696297T3 (da) Pyridobisimidazolbaseret stiv stavpolymer
RS51157B (sr) Baff receptor (bcma), imunoregulatorni agens
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
BR0108058A (pt) Corpo maciço
YU4397A (sh) Novi supstituisani oksazolidinoni
DE60133734D1 (de) Polypeptide die polymorphismen aus bordertella pertussis, bordetella parapertussis und bordetella bronchiseptica pertactin wiederholende regionen enthalten, ihre verwendung in diagnostik und immunogene zusammensetzungen
EA200201214A1 (ru) Замещенные тиоацетамиды
ATE243992T1 (de) Kosmetische zusammensetzung und deren verwendung als hautreinigungsmaske
DK0726899T3 (da) Nye pyrazincarboxamidderivater, deres fremstilling og deres anvendelse i lægemidler
ATE526994T1 (de) Mtb32a antigen aus mycobakterium tuberculosis mit inaktivierter protease aktivität und fusionsproteine die das antigen enthalten
BR0315644A (pt) Piperazinil e diazapanil benzamidas e benzotioamidas
ATE381575T1 (de) Veränderte borrelia burgdorferi ospa
DE60140972D1 (de) Antigene aus Cryptosporidium parvum, Antikörper dagegen und diagnostische und therapeutische Zusammensetzungen
ATE522230T1 (de) Biphenyle als bilderzeugungsmittel bei der alzheimerschen krankheit
AP2049A (en) Medicament containing activated antithrombin III
RU2002105454A (ru) Косметическая маска для лица
BR0316544A (pt) Compostos calcilìticos
MXPA02012015A (es) Ligandos de receptores para integrinas.
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
Chapman et al. Silence at Ramscliffe
SE0201207D0 (sv) A process for production of a regioselective membrane

Legal Events

Date Code Title Description
8364 No opposition during term of opposition